Anheuser-Busch InBev (BUD) announced on Thursday that the company is forming a new partnership with and St. Louis, Missouri-based 1st Phorm, which is a premier sports nutrition and supplements ...

Anheuser-Busch InBev SA/NV (NYSE:BUD – Get Free Report) had its price target lowered by research analysts at TD Cowen from $65.00 to $55.00 in a research note issued on Wednesday,Benzinga reports.